ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 372 filers reported holding ASTRAZENECA PLC in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,684,212 | -6.9% | 113,470 | -1.6% | 0.01% | -6.7% |
| Q2 2023 | $8,255,388 | -1.1% | 115,347 | -4.1% | 0.02% | -6.2% |
| Q1 2023 | $8,348,136 | +6.7% | 120,273 | +4.2% | 0.02% | 0.0% |
| Q4 2022 | $7,824,085 | +19.5% | 115,395 | -3.3% | 0.02% | +6.7% |
| Q3 2022 | $6,546,000 | -17.1% | 119,356 | -0.1% | 0.02% | -11.8% |
| Q2 2022 | $7,897,000 | -1.5% | 119,519 | -1.1% | 0.02% | +13.3% |
| Q1 2022 | $8,016,000 | -12.4% | 120,834 | -23.1% | 0.02% | -11.8% |
| Q4 2021 | $9,151,000 | -4.0% | 157,093 | -1.0% | 0.02% | -10.5% |
| Q3 2021 | $9,535,000 | +79.1% | 158,755 | +78.6% | 0.02% | +72.7% |
| Q2 2021 | $5,324,000 | +7.7% | 88,883 | -10.6% | 0.01% | 0.0% |
| Q1 2021 | $4,945,000 | -40.9% | 99,448 | -40.5% | 0.01% | -47.6% |
| Q4 2020 | $8,361,000 | -9.6% | 167,229 | -1.0% | 0.02% | -19.2% |
| Q3 2020 | $9,254,000 | +79.2% | 168,852 | +73.0% | 0.03% | +62.5% |
| Q2 2020 | $5,163,000 | -6.1% | 97,609 | -20.7% | 0.02% | -33.3% |
| Q1 2020 | $5,497,000 | -18.9% | 123,072 | -9.4% | 0.02% | +9.1% |
| Q4 2019 | $6,775,000 | +55.6% | 135,881 | +39.1% | 0.02% | +37.5% |
| Q3 2019 | $4,354,000 | -8.8% | 97,693 | -15.5% | 0.02% | -11.1% |
| Q2 2019 | $4,772,000 | -6.0% | 115,597 | -7.9% | 0.02% | -14.3% |
| Q1 2019 | $5,076,000 | +1.3% | 125,554 | -4.9% | 0.02% | -19.2% |
| Q4 2018 | $5,012,000 | -19.4% | 131,957 | -16.0% | 0.03% | -7.1% |
| Q3 2018 | $6,217,000 | +6.6% | 157,121 | -5.4% | 0.03% | -6.7% |
| Q2 2018 | $5,834,000 | -17.7% | 166,175 | -18.0% | 0.03% | -26.8% |
| Q1 2018 | $7,086,000 | +19.2% | 202,631 | +18.2% | 0.04% | +10.8% |
| Q4 2017 | $5,947,000 | +54.3% | 171,382 | +50.7% | 0.04% | +48.0% |
| Q3 2017 | $3,853,000 | +17.2% | 113,713 | +17.9% | 0.02% | +8.7% |
| Q2 2017 | $3,288,000 | +29.8% | 96,442 | +18.6% | 0.02% | +21.1% |
| Q1 2017 | $2,533,000 | +13.9% | 81,344 | -0.0% | 0.02% | 0.0% |
| Q4 2016 | $2,223,000 | -25.7% | 81,358 | -10.7% | 0.02% | -29.6% |
| Q3 2016 | $2,993,000 | +13.2% | 91,099 | +4.1% | 0.03% | +3.8% |
| Q2 2016 | $2,643,000 | -13.3% | 87,535 | -19.2% | 0.03% | -25.7% |
| Q1 2016 | $3,050,000 | -7.2% | 108,321 | +11.9% | 0.04% | -7.9% |
| Q4 2015 | $3,287,000 | +48.3% | 96,827 | +39.0% | 0.04% | +2.7% |
| Q3 2015 | $2,216,000 | +207.4% | 69,639 | +515.4% | 0.04% | -27.5% |
| Q2 2015 | $721,000 | -75.8% | 11,316 | -80.2% | 0.05% | -74.1% |
| Q3 2013 | $2,974,000 | -27.1% | 57,273 | -33.6% | 0.20% | +65.5% |
| Q2 2013 | $4,082,000 | – | 86,306 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |